Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/0012—Galenical forms characterised by the site of application
  • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
  • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
  • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
  • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
  • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
  • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Medicinal Chemistry (AREA)
• Engineering & Computer Science (AREA)
• Epidemiology (AREA)
• Neurosurgery (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Biomedical Technology (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Neurology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Psychiatry (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Inorganic Chemistry (AREA)
• Organic Chemistry (AREA)
• Oil, Petroleum & Natural Gas (AREA)
• Dermatology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicinal Preparation (AREA)
• Materials For Medical Uses (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=72521677

Family Applications (1)

Country Status (19)

Families Citing this family (3)

Family Cites Families (10)

• 2020
  • 2020-09-11 MX MX2022003051A patent/MX2022003051A/es unknown
  • 2020-09-11 AU AU2020346455A patent/AU2020346455B2/en active Active
  • 2020-09-11 JP JP2022516406A patent/JP7661312B2/ja active Active
  • 2020-09-11 DK DK20772437.8T patent/DK4027973T3/da active
  • 2020-09-11 CA CA3153793A patent/CA3153793A1/en active Pending
  • 2020-09-11 EP EP20772437.8A patent/EP4027973B8/en active Active
  • 2020-09-11 CN CN202080077874.0A patent/CN114727946A/zh active Pending
  • 2020-09-11 FI FIEP20772437.8T patent/FI4027973T3/fi active
  • 2020-09-11 EP EP25212808.7A patent/EP4706658A2/en active Pending
  • 2020-09-11 ES ES20772437T patent/ES3058225T3/es active Active
  • 2020-09-11 PT PT207724378T patent/PT4027973T/pt unknown
  • 2020-09-11 US US17/642,410 patent/US12383493B2/en active Active
  • 2020-09-11 LT LTEPPCT/IB2020/058474T patent/LT4027973T/lt unknown
  • 2020-09-11 SI SI202030708T patent/SI4027973T1/sl unknown
  • 2020-09-11 WO PCT/IB2020/058474 patent/WO2021048817A1/en not_active Ceased
  • 2020-09-11 HR HRP20251690TT patent/HRP20251690T1/hr unknown
  • 2020-09-11 KR KR1020227012200A patent/KR20220062372A/ko active Pending
  • 2020-09-11 PL PL20772437.8T patent/PL4027973T3/pl unknown
  • 2020-09-11 BR BR112022004535A patent/BR112022004535A2/pt unknown
• 2022
  • 2022-03-10 IL IL291283A patent/IL291283A/en unknown
• 2023
  • 2023-12-20 US US18/391,243 patent/US12128132B2/en active Active
• 2025
  • 2025-04-02 JP JP2025060885A patent/JP2025106353A/ja active Pending
  • 2025-05-12 US US19/205,563 patent/US20250268817A1/en active Pending
  • 2025-09-30 AU AU2025242078A patent/AU2025242078A1/en active Pending

Also Published As

Similar Documents